| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $146.0M | -7.0% |
| R&D Expense | $138.8M | -6.7% |
| SG&A Expense | $131.9M | -9.3% |
| Operating Income | -$129.5M | +8.9% |
| Interest Expense | $23.8M | -4.7% |
| Pre-tax Income | -$142.8M | +13.4% |
| Income Tax | $323K | -12.5% |
| Net Income | -$143.1M | +13.4% |
| EPS (Basic) | -$1.25 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.2M | -61.4% |
| Accounts Receivable | $27.0M | -42.7% |
| Inventory | $3.0M | -28.0% |
| Current Assets | $233.9M | -33.2% |
| Total Assets | $240.4M | -32.9% |
| Current Liabilities | $69.5M | +5.4% |
| Total Liabilities | $376.6M | +0.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$92.7M | +38.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $7.9M | +107.6% |
| Financing Cash Flow | $1.1M | -99.4% |
| Free Cash Flow | -$92.7M | +38.0% |
| +38.1% |
| EPS (Diluted) | -$1.25 | +38.1% |
| Stockholders' Equity |
| -$136.2M |
| -717.8% |